Measures for MIPS reporting

Explore quality measures that best fit your practice with the Academy's measure selection tool. Find your measures!

MIPS measures are used to meet the reporting requirements for the CMS' Quality Payment Program (QPP). Measures for the QPP are created by many different societies and organizations and are submitted to CMS to be approved as MIPS measures each year. 

All MIPS measures are available in the public domain and are posted on the QPP web page. Any eligible clinician is able to select MIPS measures for federal reporting. Submission methods include qualified registry (QR), EHR, qualified clinical data registry (QCDR), or claims; however, some quality measures are not able to be reported via all submission methods.

Why are measures used in pay-for-performance programs? 
Clinician participation in the Merit-based Incentive Payment System (MIPS) was created via the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).MIPS is a pay-for-performance program that uses measures as a way to collect data on the quality of care provided to patients. Measures also provide helpful feedback to practices on how they are delivering care and allow for continuous quality improvement. Learn more about MACRA in the AADA’s MACRA Resource Center

What are the different measures used for MIPS reporting? 

There are two different categories of quality measures: MIPS measures and QCDR measures. Both can be used for MIPS reporting.

  1. MIPS measures  are measures that are approved by CMS to be included in the QPP. The MACRA final rule each year also specifies the dermatology specialty measure set. This measure set is not required for dermatologists to report but labels high priority measures that are considered most applicable to dermatologists and the care they provide. Not all measures in the specialty set will be applicable to all dermatologists, but it allows for dermatologists to select a subset of measures that apply to their practice. Any eligible clinician is able to select these measures for use in MIPS.

  2. QCDR measures are measures that a medical specialty society creates and are approved by CMS for reporting in MIPS. However, these QCDR measures are not available for everyone to report on. QCDR measures can only be reported on if you report through the QCDR that owns/licenses those measures. For the AAD, DataDerm is an approved QCDR that dermatologists can use to report dermatology-specific QCDR measures.

Why should I report measures through DataDerm?

AAD’s DataDerm, a clinical data registry, has been approved as a QR and a QCDR in 2018—a designation only given by CMS. This QCDR designation allows DataDerm users the unique opportunity to report more dermatology specific measures that best fit their practice, which they otherwise would not be able to do through EHR or claims-based reporting. 

Through DataDerm, users can choose from 27 dermatology-specific quality measures for MIPS reporting. Five of these dermatology-specific, QCDR measures can only be reported through DataDerm and no other registry or EHR. If you are not a member of DataDerm and are interested in using these copyrighted measures, please contact Laura Vera.

Available measures in DataDerm include:


Looking for 2017 measures? View 2017 MIPS measures.